Lutronic announces R-GEN acquires approval of macular edema treating device

Published: 2016-10-10 11:12:05

Updated: 2016-10-10 11:12:05

On the 6th, Lutronic(CEO Hae-Ryung Hwang) announced ‘R-GEN’ acquired approval of the world’s first macula treating smart laser from the U.S. FDA. It is the first time for a Korean company to acquire approval of an ophthalmology treating device in the U.S.

The approval is associated with macular edema. It is an approval that widely relates to all the edema occurring in macular.

Lutronic will ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.